XML 101 R81.htm IDEA: XBRL DOCUMENT
v3.19.1

Business Segment Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | 12 Months Ended
--- | --- | --- | ---
Mar. 31, 2019 | Dec. 31, 2018 | Sep. 30, 2018 | Jun. 30, 2018 | Mar. 31, 2018 | Dec. 31, 2017 | Jun. 30, 2017 | Sep. 30, 2017 | Mar. 31, 2019 | Mar. 31, 2018 | Mar. 31, 2017
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill, Impairment Loss |  |  |  |  |  |  |  |  |  | $ 0 |  | $ 0 |  | $ 58,356 | [1]
amortization of inventory and property step up to fair value | [2] |  |  |  |  |  |  |  |  | 2,440 |  | 1,599 |  | 4,743 |
amortization and impairment of acquired intangible assets | [2] |  |  |  |  |  |  |  |  | 86,878 |  | 67,793 |  | 66,398 |
Business Combination, Acquisition Related Costs | [3] |  |  |  |  |  |  |  |  | 8,901 |  | 16,211 |  | 30,082 |
loss (gain) on fair value contingent consideration adjustments |  |  |  |  |  |  |  |  |  | (842) |  | (593) |  | 2,569 |
Gain (Loss) on Disposition of Business |  |  |  |  |  |  |  |  |  | (1,370) |  | 14,547 | [2] | 86,574 | [2]
Impact of TCJA on Operating Income |  |  |  |  |  |  |  |  |  |  |  | 10,264 | [4] | 0 |
Redomiciliation costs | [5] |  |  |  |  |  |  |  |  | 8,783 |  | 0 |  | 0 |
Restructuring expenses |  | $ 4,840 | $ 26,147 | $ 0 | $ 0 | $ (53) | $ 78 | $ 51 | $ 27 | 40,708 | [6] | 103 | [6] | 215 | [6]
Assets |  | 5,073,071 |  |  |  | 5,200,334 |  |  |  | 5,073,071 |  | 5,200,334 |  |  |
Payments to Acquire Productive Assets |  |  |  |  |  |  |  |  |  | 189,715 |  | 165,457 |  | 172,901 |
Depreciation, Depletion and Amortization |  |  |  |  |  |  |  |  |  | 225,921 |  | 178,332 |  | 188,142 |
Property, Plant and Equipment, Net |  | 1,031,582 |  |  |  | 1,010,524 |  |  |  | 1,031,582 |  | 1,010,524 |  |  |
Revenues |  | 768,213 | $ 696,238 | $ 678,961 | $ 638,758 | 715,973 | $ 661,900 | $ 607,964 | $ 634,159 | 2,782,170 |  | 2,619,996 |  | 2,612,756 |
Operating Income (Loss) |  |  |  |  |  |  |  |  |  | 411,465 |  | 399,883 |  | 226,206 |
Applied Sterilization Technologies [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restructuring expenses |  |  |  |  |  |  |  |  |  | 7,794 |  |  |  |  |
Assets |  | 2,655,870 |  |  |  | 2,765,269 |  |  |  | 2,655,870 |  | 2,765,269 |  |  |
Payments to Acquire Productive Assets |  |  |  |  |  |  |  |  |  | 100,077 |  | 96,193 |  | 91,240 |
Depreciation, Depletion and Amortization |  |  |  |  |  |  |  |  |  | 111,265 | [7] | 97,038 |  | 84,573 |
Revenues |  |  |  |  |  |  |  |  |  | 555,127 |  | 513,287 |  | 477,837 |
Operating Income (Loss) |  |  |  |  |  |  |  |  |  | 221,828 |  | 196,297 |  | 176,397 |
Life Science Member [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restructuring expenses |  |  |  |  |  |  |  |  |  | 664 |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 378,558 |  | 361,590 |  | 328,866 |
Operating Income (Loss) |  |  |  |  |  |  |  |  |  | 132,129 |  | 123,889 |  | 109,953 |
Life Science Member [Member] | Consumable revenues [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 161,780 |  | 150,656 |  | 143,143 |
Life Science Member [Member] | Capital equipment revenues [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 102,714 |  | 100,555 |  | 84,069 |
Life Science Member [Member] | Service revenues [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 114,064 |  | 110,379 |  | 101,654 |
OperatingSegmentAllExceptCorpandOther [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 2,782,170 |  | 2,619,996 |  | 2,612,756 |
Operating Income (Loss) |  |  |  |  |  |  |  |  |  | 741,863 |  | 672,806 |  | 612,546 |
OperatingSegmentCorpandOther [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Operating Income (Loss) |  |  |  |  |  |  |  |  |  | (184,900) |  | (162,999) |  | (137,403) |
OperatingSegmentAll [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 2,782,170 |  | 2,619,996 |  | 2,612,756 |
Operating Income (Loss) |  |  |  |  |  |  |  |  |  | 556,963 |  | 509,807 |  | 475,143 |
Healthcare and Life Sciences [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Assets |  | 1,611,852 |  |  |  | 1,621,156 |  |  |  | 1,611,852 |  | 1,621,156 |  |  |
Payments to Acquire Productive Assets |  |  |  |  |  |  |  |  |  | 49,688 |  | 52,767 |  | 39,253 |
Depreciation, Depletion and Amortization |  |  |  |  |  |  |  |  |  | 81,264 | [7] | 52,025 |  | 46,709 |
Healthcare Specialty Services [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill, Impairment Loss |  |  |  |  |  |  |  |  |  |  |  |  |  | 58,356 |
Restructuring expenses |  |  |  |  |  |  |  |  |  | 2,518 |  |  |  |  |
Assets |  | 805,349 |  |  |  | 813,909 |  |  |  | 805,349 |  | 813,909 |  |  |
Payments to Acquire Productive Assets |  |  |  |  |  |  |  |  |  | 39,950 |  | 16,497 |  | 42,408 |
Depreciation, Depletion and Amortization |  |  |  |  |  |  |  |  |  | 33,392 |  | 29,269 |  | 56,860 |
Revenues |  |  |  |  |  |  |  |  |  | 510,057 |  | 469,065 |  | 539,536 |
Operating Income (Loss) |  |  |  |  |  |  |  |  |  | 64,222 |  | 58,458 |  | 41,019 |
Healthcare Products [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restructuring expenses |  |  |  |  |  |  |  |  |  | 28,417 |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 1,338,428 |  | 1,276,054 |  | 1,266,517 |
Operating Income (Loss) |  |  |  |  |  |  |  |  |  | 323,684 |  | 294,162 |  | 285,177 |
Healthcare Products [Member] | Consumable revenues [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 414,969 |  | 412,495 |  | 403,747 |
Healthcare Products [Member] | Capital equipment revenues [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 568,811 |  | 527,402 |  | 549,238 |
Healthcare Products [Member] | Service revenues [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 354,648 |  | 336,157 |  | 313,532 |
IRELAND |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Property, Plant and Equipment, Net |  | 41,137 |  |  |  | 38,946 |  |  |  | 41,137 |  | 38,946 |  |  |
UNITED KINGDOM |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 56,784 |  | 48,246 |  | 42,733 |
UNITED STATES |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Property, Plant and Equipment, Net |  | 577,113 |  |  |  | 530,591 |  |  |  | 577,113 |  | 530,591 |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 1,976,814 |  | 1,836,414 |  | 1,803,457 |
Other foreign locations [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  | 748,572 |  | 735,336 |  | $ 766,566 |
Other Foreign Entities [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Property, Plant and Equipment, Net |  | $ 413,332 |  |  |  | $ 440,987 |  |  |  | $ 413,332 |  | $ 440,987 |  |  |
[1] | For more information regarding our goodwill impairment loss see Note 3 titled, "Goodwill and Intangible Assets"
[2] | For more information regarding our goodwill impairment loss see Note 3 titled, "Goodwill and Intangible Assets".
[3] | Acquisition and integration related charges include transaction costs and integration expenses associated with acquisitions
[4] | Represents a one-time special employee bonus paid to most U.S. employees and associated professional fees.
[5] | Costs incurred in connection with the decision to redomicile.
[6] | See Note 2 titled, "Restructuring", for more information.
[7] | The fiscal 2019 totals include the impact of Restructuring and an impairment charge. See Note 2 titled, "Restructuring" and Note 3 titled, "Goodwill and Intangible Assets", for additional information.

X
- Definition amortization and impairment of acquired intangible assets + References No definition available. + Details
Name: | ste_Amortizationandimpairmentofacquiredintangibleassets
Namespace Prefix: | ste_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition amortization of inventory and property step up to fair value + References No definition available. + Details
Name: | ste_Amortizationofinventoryandpropertystepuptofairvalue
Namespace Prefix: | ste_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Impact of TCJA on Operating Income + References No definition available. + Details
Name: | ste_ImpactofTCJAonOperatingIncome
Namespace Prefix: | ste_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition loss (gain) on fair value contingent consideration adjustments + References No definition available. + Details
Name: | ste_Lossgainonfairvaluecontingentconsiderationadjustments
Namespace Prefix: | ste_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Redomiciliation costs + References No definition available. + Details
Name: | ste_Redomiciliationcosts
Namespace Prefix: | ste_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(11)) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(12)) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 + Details
Name: | us-gaap_Assets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 23 -URI http://asc.fasb.org/extlink&oid=84229725&loc=d3e1043-128460 + Details
Name: | us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1B -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684 + Details
Name: | us-gaap_GainLossOnSaleOfBusiness
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266 + Details
Name: | us-gaap_GoodwillImpairmentLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireProductiveAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(14)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(8)) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(13)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_PropertyPlantAndEquipmentNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 5.P.3) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 + Details
Name: | us-gaap_RestructuringCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ste_AppliedSterilizationTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ste_LifeScienceMemberMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ste_ConsumablerevenuesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ste_CapitalequipmentrevenuesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ste_ServicerevenuesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ste_OperatingsegmentallexceptcorpandotherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ste_OperatingsegmentcorpandotherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ste_OperatingsegmentallMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ste_HealthcareProductsandLifeSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ste_HealthcareSpecialtyServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=ste_HealthcareProductsMemberMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_IE
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_GB
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=ste_OtherforeignlocationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=ste_OtherForeignEntitiesMemberMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |